Serological diagnosis of Dengue virus infection in travellers; the impact of cross-reacting flaviviridae antigens.

Completed

• Conditions: Breakbone fever; 10047438

• Registration Number: NL-OMON37829
• Lead Sponsor: niversitair Medisch Centrum Sint Radboud

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 20

Inclusion Criteria

The research population is defined as healthy volunteers (>18-years old) who received a Yellow Fever vaccination or a Tick Born Encephalitis vaccination.

Exclusion Criteria

Immuno-compromised patients or pregnancy.
Patients with known coagulopathias.

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The main parameter is specificity and positive predictive value of the Dengue<br /><br>IgG ELISA.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>nvt</p><br>